Dr Martens shares tanked yesterday as investors ditched a chunk of shares on the cheap.
In the latest blow to the Northampton-based bootmaker, Goldman Sachs sold around 70m shares on behalf of a group of investors.
The stock was sold at 57.85p per share – a discount of around 10 per cent to the firm’s last closing price.
That sent the stock down 19.4 per cent, or 12.45p, to 51.65p. The company is valued at around £500m. Dr Martens floated to much fanfare in January 2021 with a £3.7billion valuation. But it has struggled ever since with production and material costs spiralling.
That has sparked a series of profit warnings from the group – made worse from a weak performance in the US.
Danni Hewson, analyst at AJ Bell, said the latest sell-off has ‘shaken confidence even further’. And Susannah Streeter, of Hargreaves Lansdown, said the firm ‘has failed to boot away its recent troubles’.
DIY INVESTING PLATFORMS
AJ Bell
AJ Bell
Easy investing and ready-made portfolios
Hargreaves Lansdown
Hargreaves Lansdown
Free fund dealing and investment ideas
interactive investor
interactive investor
Flat-fee investing from £4.99 per month
Saxo
Saxo
Get £200 back in trading fees
Trading 212
Trading 212
Free dealing and no account fee
Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.
Compare the best investing account for you
